A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

By Robert R. Graham, S. Kozyrev, Emily C. Baechler, M. P. L. Reddy, Robert M. Plenge, J. Bauer, W. Ortmann, T. Koeuth, M. G. Escribano, B. Pons-Estel and 7 more. Nature Genetics, 2006

710 citations recorded by the source corpus.

Subfields: Immunology, Oncology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/7b0b03ddbb1ff282dd32f2df101d75adb630c246

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Jacques Banchereau
2. V. Pascual
3. Robert M. Plenge
4. K. Palucka
5. C. A. Dinarello

In Oncology

1. Jacques Banchereau

In Rheumatology

1. P. Tak

Citations in the corpus

• Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci (2010, background): “8 × 10 −6 ), chosen because of its association with SL”
• Type I interferon in systemic lupus erythematosus and other autoimmune diseases. (2006, background): “The association of SLE with IRF5 polymorphisms giving rise to unique IRF-5 isoforms has been confirmed across different ethnic backgrounds (Graham et al., 2006).”